cervical cancer
Conditions
Interventions
control group:Nil
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. The clinical stage was IA2-IIA1; 2. According to NCCN guidelines, there were no high risk factors, but only one moderate risk factor according to Sedlis criteria; 3. Female patients aged 20-75 years old; 4. There were no other malignant tumors; 5. Blood routine examination and normal range of liver and kidney function; 6. Patients have the willingness and ability to sign informed consent and can accept all visits specified by the trial protocol; 7. Life expectancy is more than 3 years.
Exclusion criteria
Exclusion criteria: 1. Patients who had received abdominal radiotherapy before; 2. Patients with advanced or recurrent cervical cancer; 3. Uncontrolled concurrent diseases, but not limited to: severe uncontrolled infection, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled hypertension or mental disease, severe cerebrovascular disease; 4. Other situations in which the researcher believes that the patient is not suitable to participate in the study; 5. Acquired immunodeficiency syndrome; 6. Known platinum allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse free survival;overall survival;CD8+CD28+ T cells;CD4+CD25+T/CD4+T; | — |
Countries
China
Contacts
Public ContactSun Yunyan
Shanghai General Hospital
Outcome results
None listed